<DOC>
	<DOCNO>NCT00706550</DOCNO>
	<brief_summary>The purpose study evaluate best time administer pneumococcal vaccine ( PV ) HIV-infected adult CD4 cell count 200 yet receive combination antiretroviral treatment ( ART ) . Participants study assign chance receive vaccination PV prior start ART least 6 month ART . Antibody level component PV measure 6 month 12 month vaccination . The result tell u patient receive PV 6 month ART good response vaccine get vaccinate prior treatment .</brief_summary>
	<brief_title>Immune Responses Pneumococcal Vaccination Among HIV-infected Subjects</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>HIV infect CD4 count &gt; 200 acute illness pneumococcal vaccination within 3 year naive treatment previously treatment , antiretroviral treatment least 6 month willingness start antiretroviral treatment recommend current guideline prior pneumococcal vaccination within 3 year prior AIDS diagnosis base opportunistic disease acute illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>pneumococcal polysaccharide vaccine</keyword>
</DOC>